Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells. - Wikidata - thesis-toulmin - TriplyDB

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

http://www.wikidata.org/entity/Q34757252

about

Targeted DNA mutagenesis for the cure of chronic viral infections Genome-editing Technologies for Gene and Cell Therapy Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases Targeted gene disruption to cure HIV Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia Genome-Edited T Cell Therapies.CRISPR/Cas9, a powerful tool to target human herpesviruses.High frequency targeted mutagenesis using engineered endonucleases and DNA-end processing enzymes.Genome editing and the next generation of antiviral therapy.In vivo disruption of latent HSV by designer endonuclease therapy RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection.Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors Proviral HIV-genome-wide and pol-gene specific zinc finger nucleases: usability for targeted HIV gene therapy.AAV-mediated delivery of zinc finger nucleases targeting hepatitis B virus inhibits active replication Zinc-finger nucleases for somatic gene therapy: the next frontier.Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.The Structural Basis of Asymmetry in DNA Binding and Cleavage as Exhibited by the I-SmaMI LAGLIDADG Meganuclease.In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing Endonuclease Generation of novel nucleases with extended specificity by rational and combinatorial strategies.Towards artificial metallonucleases for gene therapy: recent advances and new perspectives.Molecular scissors for in situ cellular repair.Targeted gene therapies: tools, applications, optimization Recent advances in targeted genome engineering in mammalian systems.Biological and biomedical applications of engineered nucleases.DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells.Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools.Antiviral Defenses in Plants through Genome Editing.Attitudes and Willingness to Assume Risk of Experimental Therapy to Eradicate Genital Herpes Simplex Virus Infection.Targeting herpetic keratitis by gene therapy.Homing endonucleases from mobile group I introns: discovery to genome engineering.Gene transfer of integration defective anti-HSV-1 meganuclease to human corneas ex vivo.TALENs targeting HBV: designer endonuclease therapies for viral infections.Meganuclease-mediated virus self-cleavage facilitates tumor-specific virus replication.Crystallographic analyses illustrate significant plasticity and efficient recoding of meganuclease target specificity.Genome editing technologies to fight infectious diseases.Chemical Approach to Biological Safety: Molecular-Level Control of an Integrated Zinc Finger Nuclease.Engineering altered protein-DNA recognition specificity.

P2860

Q24620150-F7F55FE5-F10C-4683-9416-7D31650D10E9 Q26769662-E6B5A2D7-4492-46B0-BB36-CE696332B7FA Q27011249-C6B11355-6E89-4F37-B4B0-804DE293A376 Q27023171-2C21EB34-D098-447A-B64E-D085BA80CBA1 Q28087526-885CF871-FC93-40CA-8976-FD58332C8697 Q33680976-C9F557A4-80E9-47DC-8368-EEB447090776 Q33729598-A8B9F6C6-B3EB-4B6D-A530-0642A8A0297E Q34047704-32A6AB2E-7985-4E07-B31A-A2AF77B2AC98 Q34325057-F4E5B9B0-3955-4D48-AEF2-A10B006532A3 Q34529971-CD8F85E9-A4A5-4736-A2DD-DEBD37687F96 Q34540648-79FD7170-5102-4854-82F7-2974CA733C62 Q34583415-759778D0-3BB1-4D2C-9830-90252B27DEE4 Q35111489-4EFA7AC4-16DD-429D-975B-C81D48E8A4EE Q35154903-094140A9-DC94-4904-9970-844B6A3DABD2 Q35168444-708B6A22-00AA-45CF-8DFA-707C239433A2 Q35174917-71B6F730-38B5-44E7-8E6C-8A66EEACD817 Q36494284-79AB71E3-F3E4-43CE-BEFC-7700DC503D38 Q36567836-AA8ED576-3655-4D8C-B5A1-C38337708CDF Q37634060-10E5538F-7CF6-4A61-9653-45C225BB1FFF Q37874216-A9E2F0A7-FD13-4900-8152-F77025EF7C23 Q37948867-A08B2F3F-020B-414B-96B3-A2D358E76020 Q37979243-4617AA18-F873-4677-8D32-2DD8DE336D7C Q38005211-B3A87510-782D-4E13-89F7-D621C0CE959B Q38025056-02C7AABF-68A7-4292-8EF8-CCD0DED3752E Q38054450-07E6C8BF-3F33-432D-BFFA-588EC08E42E7 Q38184158-CCE4F714-1D41-48D9-BFEB-45C863FE96A6 Q38209315-9EBEFBAF-0326-46DB-BDA4-01FDD4F3E1C4 Q38770194-B48D5FC2-8AFD-451F-87A7-C6B6BA0ACCA6 Q39123386-3E7CE40F-D992-4D9C-BFDE-1E647E79508A Q40579974-8CB2E905-6B30-4D33-9E90-64207107E9ED Q41951959-8F40C1B7-B93C-41CA-9469-E7F741FE0983 Q42000691-7BF844C9-BFFC-40FC-96F7-1FFBEA32812A Q42242985-36157B7C-5C6F-4264-9C86-6053175BEA1B Q42245971-55CAA6F7-C5FA-43CD-BCD8-9CA8FAE89016 Q42633568-817299DC-6399-4964-A0EA-28589583C3B1 Q44166529-60551276-285F-41BD-AF0D-869FEAD6EC3B Q47392998-B16B58D8-59EA-45E8-A522-A5D096979A64 Q48114494-1851FD4F-C09F-4725-9CED-A47950EF159C Q55359800-3DADDFF0-BF2A-446A-B3B3-AA64C2527ABA

P2860

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

http://www.wikidata.org/entity/Q34757252

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

@ast

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

@en

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

@nl

type

label

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

@ast

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

@en

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

@nl

prefLabel

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

@ast

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

@en

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

@nl

P1433

Q34757252-7ECDBD9A-13CD-4D76-B863-FF47A51CFE17

P1476

Q34757252-2C1EABF8-E599-4C34-81F5-6B3323EFC472

P2093

Q34757252-0870544E-C0D4-4621-AF29-6DC486FCCCDE

Q34757252-11F5EFF5-9680-4968-A5BE-E85972E5EA19

Q34757252-2A631199-EB7F-4D27-8BD6-95FAA5FC4C53

Q34757252-37EF7E8F-5894-49EC-89EC-929752551511

Q34757252-43EA1F80-063A-41FA-83E1-885AACDE4186

Q34757252-4D2AD16C-DEFE-4C64-A15C-47DDF14E5FFE

Q34757252-5012DF47-5EE8-4B52-BF67-D504E54EB0A0

Q34757252-5FF421FA-A6EF-486D-8A1F-87D48593458A

Q34757252-7BE81F1B-1BA4-443C-AFA2-76D5C2E0B2B0

Q34757252-7FA8072F-4BDB-42A2-9043-ABCEE207DB6B

P2860

Q34757252-0263A17C-5B8E-4A6B-9401-764C605164EB

Q34757252-049EB909-ECA5-4786-8C14-3C9FCA87BB22

Q34757252-08C1B3A9-C36B-4AF6-BF62-8ECF348D537B

Q34757252-08DBEE1F-AB61-4BC8-AFE5-759D52E83062

Q34757252-0DD7F833-4426-4B90-A428-1DA9A847F6A9

Q34757252-1B1918B0-D4DB-4702-B9C7-0A98A72831D8

Q34757252-20B6052C-26D8-4D0C-B529-33A5A9824E3E

Q34757252-217EE806-10E2-45CE-9A6B-9FF61927C1CF

Q34757252-2F9D7DB4-B72E-4BC5-A596-D79815215A0E

Q34757252-37CFA299-0733-47E8-941D-B4BAE037ED29

P304

Q34757252-E04966C7-F004-44FC-A195-22DC8259502D

P31

Q34757252-34FFE7C0-5FD6-433C-BA51-649BA755447D

P356

Q34757252-B6D72B9E-D39D-40A4-8E41-C6C140D8DBB2

P433

Q34757252-E7073532-8569-4EA3-98D9-CC8EF1D81019

P478

Q34757252-0C5334AF-77CC-4094-9B74-B4120955D994

P577

Q34757252-EBD005B1-E2C5-4697-A084-08278FBDE6B2

P5875

Q34757252-21DEE161-0887-43C4-B26B-31D4AAE1A7A7

P698

Q34757252-69AAEE2F-00AB-4281-976A-46948AE85287

P932

Q34757252-F03B6EBE-D32A-44AD-B1F7-D573A6ED7EC5

P356

P1433

Molecular Therapy

P1476

Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

@en

P2093

Ayla Ergani

http://www.w3.org/2001/XMLSchema#string

Benoît Chapellier

http://www.w3.org/2001/XMLSchema#string

Carole Desseaux

http://www.w3.org/2001/XMLSchema#string

Charlotte Mahiet

http://www.w3.org/2001/XMLSchema#string

Cécile Jacqmarcq

http://www.w3.org/2001/XMLSchema#string

Diane Le Clerre

http://www.w3.org/2001/XMLSchema#string

Emmanuel Conseiller

http://www.w3.org/2001/XMLSchema#string

Frédéric Cédrone

http://www.w3.org/2001/XMLSchema#string

Frédéric Pâques

http://www.w3.org/2001/XMLSchema#string

Isabelle Chion-Sotinel

http://www.w3.org/2001/XMLSchema#string

P2860

Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair

Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae

Computational redesign of endonuclease DNA binding and cleavage specificity

Generation of redesigned homing endonucleases comprising DNA-binding domains derived from two different scaffolds

Progress and prospects: zinc-finger nucleases as gene therapy agents

Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification

Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae

Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease

A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences

Homing endonuclease I-CreI derivatives with novel DNA target specificities

P304

694-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2010.302

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49745662

http://www.w3.org/2001/XMLSchema#string

P698

21224832

http://www.w3.org/2001/XMLSchema#string

P932

3070101

http://www.w3.org/2001/XMLSchema#string